Please login to the form below

Not currently logged in
Email:
Password:

Archimed

This page shows the latest Archimed news and features for those working in and with pharma, biotech and healthcare.

Fishawack undergoes management buyout

Fishawack undergoes management buyout

In recent years the agency's acquisitions have included UK med comms agency Facilitate, US group JK Associates and Swiss agency  Archimed..

Latest news

  • ArchiMed acquires life sciences consultancy Deallus ArchiMed acquires life sciences consultancy Deallus

    ArchiMed, Europe's first independent private equity healthcare specialist, has acquired majority control of Deallus Consulting. ... D'Ambrosio added that acquiring Deallus would enable ArchiMed to be more involved in pharma services.

  • Archimed drug safety specialists rebrand Archimed drug safety specialists rebrand

    Changes name to Fishawack Archimed following integration. Archimed Medical Communication is now known as Fishawack Archimed. ... Founded in 1997 in Zofingen, Switzerland, Fishawack Archimed has developed into a specialist provider of drug safety and

  • Fishawack Group acquires Archimed Medical Communication

    Based in Zofingen, Switzerland, Archimed offers clients medical writing, project management, and clinical research, consultancy and pharmacovigilance services. ... We are very excited to have Archimed join the Group,” said Oliver Dennis, Fishawack CEO.

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....